language-icon Old Web
English
Sign In
Acemap > Paper > Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation

2016 
Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    32
    References
    24
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.